NIH-funded research NIH-funded research

Using natural microbial mixtures to create better antibiotic combinations

Official title: Discovery and development of drug cocktails evolved by Nature

Funded at Texas Engineering Experiment Station · NIH-11320858 · Data updated 2026-11-12

Finding natural combinations of compounds to make antibiotics that work better for people with drug-resistant infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startJuly 1, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$346,389
NIH project number5R35GM146984-05
Project IDNIH-11320858 on NIH RePORTER

Who could benefit from this research

Could help

People with drug-resistant bacterial infections would be the most likely candidates for any future clinical testing based on these findings.

Less likely to help

This laboratory-focused research does not directly help people with viral infections or non-infectious conditions.

What this research studies

From a patient point of view, the team is looking at how microbes naturally make sets of compounds that work together and using those recipes to find stronger antibiotic mixes. They will use genome data to predict which compounds are co-produced, test mixtures in the lab for synergy against drug-resistant bacteria, and develop ways to make promising combinations. The work focuses on reducing the chance that bacteria become resistant and on producing mixtures that could be developed into therapies. These are laboratory steps that could guide later testing in people if promising candidates are found.

Why it matters

Potential benefit: Could lead to new combination antibiotics that are more effective against drug-resistant infections.

How similar studies have gone: There are known examples where natural product combinations work against bacteria, but using genome-guided discovery of co-produced synergistic mixtures is a newer and less-tested approach.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Zhu, Xuejun — Texas Engineering Experiment Station
  • Study coordinator: Zhu, Xuejun

Related research

Other NIH-funded projects on the same topics.

  • Robotic dental implants to deliver stem cells

    A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11591543

  • Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis

    A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11577865

  • Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk

    This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11456681

  • Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones

    A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11449053

  • Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer

    Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448647

  • Targeted nanoparticle therapy for lung fibrosis

    A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448075

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.